New Evidence Early Tx Improves Preclinical MS Outcomes
The disease-modifying drug teriflunomide reduces the risk of developing clinical multiple sclerosis by 72% in radiologically isolated syndrome.
Stay updated with breaking news from Multiple Sclerosis Ms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The disease-modifying drug teriflunomide reduces the risk of developing clinical multiple sclerosis by 72% in radiologically isolated syndrome.
Catherine M. DiGiorgio, MD, MS, found herself at a crossroads: stay and work for a large corporation or open a solo practice?
Sandoz's natalizumab-sztn injection (Tyruko) is on par with Biogen's Tysabri (natalizumab) for treatment of relapsing forms of MS, the FDA said in approving the first biosimilar to treat MS.
Smoking has been linked to more rapid MS progression and greater disease severity but new data suggest oral tobacco use tied to slower disease progression.
Did you know that stress can have physical manifestations in unique areas of our bodies? On World Brain Day, Midday Online spoke to a psychologist to uncover ho